Heat shock protein: a hot topic in idiopathic pulmonary fibrosis

Philippe Bonniaud, Pierre-Simon Bellaye, Olivier Burgy, Martin Kolb

Source: Eur Respir J , 49 (2) 1602152; DOI: 10.1183/13993003.02152-2016
Journal Issue: February
Disease area: Interstitial lung diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Philippe Bonniaud, Pierre-Simon Bellaye, Olivier Burgy, Martin Kolb. Heat shock protein: a hot topic in idiopathic pulmonary fibrosis. Eur Respir J , 49 (2) 1602152; DOI: 10.1183/13993003.02152-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Heat shock protein-90 toward theranostics: a breath of fresh air in idiopathic pulmonary fibrosis
Source: Eur Respir J, 51 (2) 1702612; 10.1183/13993003.02612-2017
Year: 2018



Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015

Heat shock proteins (HSP)-10 and –40 increase in bronchial biopsies of patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


The potential role of intracellular heat shock protein 70 deficiency in aging and pulmonary fibrosis.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017


Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017


Mycobacterial heat shock proteins in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008


Serum heat shock protein levels in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014

Severe idiopathic pulmonary fibrosis: what can be done?
Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017
Year: 2017



Increased expression of heat shock protein 70 in COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010

Serum heat shock protein 47 levels in patients with drug induced lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Expression of heat shock proteins in chronic obstructive pulmonary disease, vernal keratoconjunctivitis and ulcerative colitis
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016


Categorising sub-massive pulmonary thromboembolism: no isolated role for shock index or its modified form
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019


Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias
Source: Eur Respir J 2007; 29: 134-137
Year: 2007



Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Heat shock protein (HSP) 72 polymorphism in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005

Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014

Hypoxemic resuscitation of hemorrhagic shock attenuates the pulmonary oxidative and inflammatory responses
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005